DaBomb Protein Biotech Corp. (TPEX:6578)
Taiwan · Delayed Price · Currency is TWD 18.10
+0.15 (0.84%)
Aug 19, 2026, 10:05 AM CST
DaBomb Protein Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 339.44 | 309.34 | 337.82 | 384.41 | 433.63 | 470.63 |
Revenue Growth | 13.87% | -8.43% | -12.12% | -11.35% | -7.86% | -22.24% |
Gross Profit Gross Profit Growth | 80.8 | 69.04 | 68.73 | 46.43 | 19.33 | 21.65 |
Operating Income Operating Income Growth | -21.51 | -28.18 | -1.82 | -29.93 | -62.47 | -63.77 |
Net Income Net Income Growth | -41.91 | -69.34 | 11.64 | -57.03 | -44.66 | -62.45 |
Earnings Per Share EPS Growth | -0.57 | -0.96 | 0.17 | -1.07 | -1.15 | -1.92 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Vietnam Vietnam Growth | 115.94 | 179.2 | 219.23 | 219.05 | 254.26 |
Taiwan Taiwan Growth | 82.5 | 78.96 | 85.37 | 56.86 | 50.58 |
United States United States Growth | 80.19 | 36.52 | 39.3 | 17.9 | - |
Malaysia Malaysia Growth | 14.93 | 17.68 | 9.79 | 20.4 | 30 |
Others Others Growth | 15.77 | 25.47 | 11.89 | 12.82 | 26.54 |
Total Total Growth | 309.34 | 337.82 | 384.41 | 433.63 | 470.63 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 168.72 | 132.17 | 253.59 | 380.07 | 195.18 | 197.14 |
Total Debt Total Debt Growth | 68.5 | 74.21 | 168.13 | 417.6 | 495.59 | 618.01 |
Net Cash (Debt) Net Cash Growth | 100.23 | 57.96 | 85.45 | -37.53 | -300.41 | -420.87 |
Net Cash Growth | 16.84% | -32.18% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.36 | 0.81 | 1.19 | -0.70 | -7.76 | -12.96 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 40.27 | 16.65 | 47.55 | 6.51 | 19.71 | -44.25 |
Capital Expenditures CapEx Growth | -15.02 | -37.69 | -30.24 | -18.87 | -19.99 | -332.09 |
Free Cash Flow Free Cash Flow Growth | 25.25 | -21.04 | 17.32 | -12.37 | -0.29 | -376.35 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 23.80% | 22.32% | 20.34% | 12.08% | 4.46% | 4.60% |
Operating Margin | -6.34% | -9.11% | -0.54% | -7.79% | -14.41% | -13.55% |
Pretax Margin | -10.06% | -21.45% | 4.76% | -14.55% | -11.31% | -15.22% |
Profit Margin | -12.35% | -22.41% | 3.45% | -14.83% | -10.30% | -13.27% |
FCF Margin | 7.44% | -6.80% | 5.13% | -3.22% | -0.07% | -79.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.400 | - | 0.170 | 0.550 | 1.000 |
Dividend Per Share Growth | -21.45% | - | -69.09% | -45.00% | - |
Dividend Yield | 2.22% | - | 0.88% | 2.74% | 6.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 114.64 | - | - | - |
P/FCF Ratio | 51.14 | - | 77.04 | - | - | - |
PS Ratio | 3.80 | 4.44 | 3.95 | 3.25 | 1.47 | 1.23 |